|
Post by longtimerhere on Feb 2, 2019 11:56:32 GMT -5
Overall Thoughts on MNKD
The Past -- BP pressures and MNKD management missteps caused a train wreck that sadly we witnessed first hand.
The Present -- The definition of insanity -- doing the same thing over and over and expecting different results. MNKD management continues to throw millions of dollars into the Afrezza money pit. A high-price to run T.V. commercial that never says "No Needles" or "Less Needles". A multi-million dollar promotion plan and sales force effort that yields a huge Negative ROI. Lather, Rise and Repeat. It's Insanity. The Future -- Management will push Afrezza and run the bank accounts dry, then do a stock raise to get more money until that well runs dry. The Bank of Al Mann floated MNKD for a long time and covered a lot of management mistakes. Have you noticed the Mann Trust won't give us a dime anymore? Unless Afrezza is sold off and MNKD refocused to being a molecule development company we are doomed. (Not a negative rant but a true reality that at least Sports sees)
|
|
|
Post by akemp3000 on Feb 2, 2019 12:07:32 GMT -5
Yawn...Whiners of Mannkind have been predicting its demise like this for years. Most people realize Mike Castagna has done an excellent job in the past year and a half turning this company around in so many categories. The company is now positioned better today to move forward than at any moment in the past. This might possibly be a "last post" under this particular name but no doubt the same perspective will magically reappear under another new name. Nice try
|
|
|
Post by letitride on Feb 2, 2019 12:20:20 GMT -5
Gonna miss ya!
|
|
|
Post by Omega on Feb 2, 2019 12:23:44 GMT -5
72 hour old account, 12 posts, 4 new threads all saying the same crap over and over.
Bye Felicia
See your new account tomorrow, you won't be able to stay away from this lovely bunch for long.
|
|
|
Post by falconquest on Feb 2, 2019 12:28:43 GMT -5
Yawn...Whiners of Mannkind have been predicting its demise like this for years. Most people realize Mike Castagna has done an excellent job in the past year and a half turning this company around in so many categories. The company is now positioned better today to move forward than at any moment in the past. This might possibly be a "last post" under this particular name but no doubt the same perspective will magically reappear under another new name. Nice try I sympathize with the OP. The "yawn" is waiting for something to happen...............and waiting....................still waiting.................and waiting (ie. share price). The "move forward" statement somehow seems redundant.
|
|
|
Post by sexychefski on Feb 2, 2019 12:38:07 GMT -5
What a noob. Come back when you have two stars. #MNKDtodamoon2019
|
|
|
Post by sportsrancho on Feb 2, 2019 12:46:59 GMT -5
I don’t know who the poster is, but I feel we have a few months to prove Mike’s efforts are going in the right places. Spencer wrote an article this morning... Basically he was stating the bottom line with no surprises. Of course I’m hoping for surprises:-) I think Nate expects a inflection point soon. I don’t think he would be surprised if the scripts jumped within the next few weeks, not because of the TV ads all together, but also because of where we are in his projection time line and inflection points with doc’s. If that happens then everything changes, we can get a loan, we can get a partner, everybody will see success ahead for Afrezza. If not then the pps suffers and it will be hard to raise money at all. And signing it off to someone else could be better for the company if they have ability to market the drug properly. Stock price right now is based on Afrezza being a flop, either way they go whether Afrezza excels or they sell it, it’s going to be better for the stock price. We can talk about it all day but it’s the company that’s going to have to make that decision.
|
|
|
Post by seanismorris on Feb 2, 2019 12:48:22 GMT -5
It’s pretty incredible how long a public company can bleed cash and still stay in business.
MannKind isn’t going out of business any time soon...
Is the risk/reward attractive? That’s another question entirely.
Personally, selling for pennies on the dollars isn’t attractive...
|
|
|
Post by longtimerhere on Feb 2, 2019 14:01:46 GMT -5
I don’t know who the poster is, but I feel we have a few months to prove Mike’s efforts are going in the right places. Spencer wrote an article this morning... Basically he was stating the bottom line with no surprises. Of course I’m hoping for surprises:-) I think Nate expects a inflection point soon. I don’t think he would be surprised if the scripts jumped within the next few weeks, not because of the TV ads all together, but also because of where we are in his projection time line and inflection points with doc’s. If that happens then everything changes, we can get a loan, we can get a partner, everybody will see success ahead for Afrezza. If not then the pps suffers and it will be hard to raise money at all. And signing it off to someone else could be better for the company if they have ability to market the drug properly. Stock price right now is based on Afrezza being a flop, either way they go whether Afrezza excels or they sell it, it’s going to be better for the stock price. We can talk about it all day but it’s the company that’s going to have to make that decision. Sports thanks for your correct thoughts on MNKD. To others: Why is getting rid of a million-dollar drain (Afrezza) a bad thing? Answer: It's not.
|
|
|
Post by sportsrancho on Feb 2, 2019 14:17:03 GMT -5
The important thing to me is we don’t limp along wasting our opportunities to promote the other drugs in the pipeline. Or letting the share price decline so we are unable to get other funding. If we can get some traction with Afrezza we will have all kinds of opportunities. We all trying our hardest on the awareness front.
|
|
|
Post by sayhey24 on Feb 2, 2019 14:35:07 GMT -5
Sports - hang in there. It has taken a really long time but the medical community is now just starting to feel the pressure of seeing BG numbers in real time. We all know there are only two ways to treat the post meal sugar spike; not eat the food; take the afrezza.
Afrezza will have its day. It won't be in 6 months but Mike is making progress and so is Dave Kendall. At the same time CGM technology adoption is rapidly growing and costs are within reach of most even with no insurance. For $4 a day for the afrezza and $2.80 a day for a Libre sensor we are now under the price Kevin Johnson is selling a cup of coffee and a doughnut. In the mean time maybe Kevin with give us news on RLS to extend the runway.
|
|
|
Post by tingtongtung on Feb 2, 2019 14:43:07 GMT -5
The important thing to me is we don’t limp along wasting our opportunities to promote the other drugs in the pipeline. Or letting the share price decline so we are unable to get other funding. If we can get some traction with Afrezza we will have all kinds of opportunities. We all trying our hardest on the awareness front. You know what's scary? Here, and in the other recent thread (forgot the title), some very loyal followers are almost talking about selling off Afrezza implying MNKD cannot make Afrezza a viable product. Afrezza is a very good product. We have been in business for a long time. We have seen how Exubera failed, we learned from that, and made Afrezza a better product. Various external factors caused too many problems leaving us in this situation. But, MNKD cannot and shouldn't run away. We are not charity, and we have to make money. But, MikeC and his team HAS to come up with a viable plan. There is nothing wrong with the drug. Everything wrong is with the eco-system. You cannot keep complaining about how unfair is this, that and something else. As I and few of us suggested a long time back, MNKD has to pick 3/4 states and flood with sales people, ads, etc., and get the scripts rolling like yesterday. 700-800 scripts is almost a joke. I'm not downplaying their effort. But honestly, 800 scripts (which includes refill) among several million people for such a drug is a joke. The ad is crazy. I'm not an ad/media guy. But, there is nothing that stands out. Why can't they have something like, "Just breathe", "No needles"(from a post above), "showing a person taking Afrezza in a restaurant), etc, etc. These are more compelling than a purple tree in park, or a floating burger. And BoD has to tie more stock to the compensation. No question about that. A lot of us own more than what the CxO guys own.
|
|
|
Post by sayhey24 on Feb 2, 2019 14:54:41 GMT -5
Tingtong - there is one thing wrong with afrezza which MNKD can readily fix. The calling of the cartridges as units was a huge marketing blunder. This was an effort on the part of Al Mann to learn from Exubera dosing as he thought it would make it easy.
What is has done is have PWDs under dose and want to compare to RAA dosing. Mike should ask for them to be renamed small, medium and large. The more we can get away from traditional "insulin" the better. As we move more into the T2 space the use of the word "insulin" should be suppressed. T2s should just be taking a small, medium or large glucose buster after each meal.
|
|
|
Post by sportsrancho on Feb 2, 2019 14:54:46 GMT -5
I think pretty much everybody agrees we need a restaurant commercial.
The money that should’ve been raised a long time ago was not raised and we’ve all talked about that to exhaustion, but now Mike’s got to get the share price up and get those warrants exercised so they’re not holding everything down, or no one is going to like what happens. And that’s whats scary to me.
|
|
|
Post by joeypotsandpans on Feb 2, 2019 16:09:24 GMT -5
Last time we heard a "last post from me" title was LFD and we see where that went lol...you speak in terms of "our investment" and then give the ad nauseam cliche of defining insanity, well if you still own the stock after 11yrs. I guess by your own definition you're insane . Falconquest, last I remember you said you sold your position and were waiting to re-enter when you felt it was a better situation but yet you also speak in "our investment" terms... Got to love the half dozen or so "advisors" looking out for everyone's interest, don't recall meeting any of you at the last SH meetings... For whatever reasons folks originally or recently invested THEIR money into this founder/company they always had a choice...put their cash with a managed account advisor or via their own due diligence make an investment in something they personally believe in. Pretty sure most if not all are adults on here and think independently and that most if not all recognize the risk/reward scenarios involved with investing in upstart biotech companies. If not then by all means they've gotten the education of a lifetime. So where we have a group of financial advisors and Monday morning and/or armchair quarterbacks on here and you all know who you are, I think most longs here understand the current situation and can make their own decisions if they wish to continue to remain with their investment thesis or cut bait, but hey thanks for stopping by and as someone near and dear use to say...don't let the door slap you on the way out
|
|